Atlas Trials

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

Clinical trial NCT03418831 · COMPLETED

Trial details

NCT number
NCT03418831
Sponsor
Shanghai Mental Health Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2018-07-17
Primary completion
2019-04-30
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.